Supratentorial Palsy: Diagnosis and Treatment
The term "supratentorial palsy" appears to be a misnomer or confusion with either superior oblique palsy (an ophthalmologic condition) or progressive supranuclear palsy (a neurodegenerative disorder)—these require completely different diagnostic and therapeutic approaches, so clarifying which condition is suspected based on presenting symptoms is the critical first step.
Diagnostic Algorithm Based on Presentation
If Patient Presents with Diplopia, Hypertropia, or Abnormal Head Tilt:
Suspect Superior Oblique Palsy and proceed with:
- Park's three-step test: Look for hypertropia that increases on contralateral gaze and ipsilateral head tilt 1
- Prism bar cover test (PBCT): Quantify vertical deviation in all gazes (typically >25 PD in severe cases) 2
- Triple forced duction tests: Assess for SO tendon laxity, absence, or ipsilateral superior rectus contracture 3
- MRI head and orbit: Rule out structural lesions (though often normal in idiopathic cases) 2
- Myasthenia and inflammatory workup: Exclude secondary causes 2
Treatment for Superior Oblique Palsy:
- Trial of oral corticosteroids at 1 mg/kg body weight for idiopathic acquired cases, particularly if inflammatory etiology suspected 2
- Monitor response at 6 weeks; if diplopia resolves, taper by 10 mg weekly 2
- Surgical intervention (inferior oblique weakening procedures) achieves symptom elimination and hyperdeviation neutralization in 77% of cases when conservative management fails 1
- Maintain minimum effective steroid dose (often 10 mg daily) if steroid-dependent 2
If Patient Presents with Gait Ataxia, Falls, Vertical Gaze Palsy, or Parkinsonism:
Suspect Progressive Supranuclear Palsy (PSP) and proceed with:
- Orthoptic oculomotor assessment: Evaluate saccadic velocity, vertical gaze limitation (especially downgaze), doll's head maneuver, vergence, and eyelid signs—this achieves 80.77% diagnostic consistency with final neurological diagnosis 4
- Eye-tracker assessment: Quantifies oculomotor dysfunction objectively 4
- MRI brain: Look for midbrain atrophy ("hummingbird sign"), though imaging may be normal early 5
- PET imaging and fluid biomarkers: Emerging tools for differentiation from other tauopathies 5
- Distinguish from multiple system atrophy-cerebellar type (MSA-C) which shares overlapping features with PSP-cerebellar predominance variant 6
Treatment for Progressive Supranuclear Palsy:
- Comprehensive physiotherapy program: Transfer training, fall prevention strategies, activities of daily living promotion, and targeted interventions for rigidity/tremors 6
- Multidisciplinary team approach: Physical therapy, occupational therapy, speech therapy for dysarthria 5
- No disease-modifying treatments currently available; management focuses on symptomatic relief and quality of life 5
Critical Pitfalls to Avoid
Do not confuse supranuclear lesions with peripheral nerve palsies: Rare cases of splenial infarction can mimic peripheral facial palsy without forehead sparing 7. When facial palsy presents atypically, obtain MRI to exclude central causes even if peripheral features dominate.
Do not miss bilateral superior oblique palsy: Masked bilateral cases present diagnostic challenges; look for bilateral inferior oblique overaction and history of symptoms from childhood or trauma 1.
Do not misdiagnose PSP variants: PSP-cerebellar predominance is frequently misidentified as MSA-C due to shared cerebellar features—careful attention to oculomotor findings and evolving clinical criteria improves accuracy 6, 5.
The provided guideline 8 addresses cerebrovascular stroke imaging protocols but does not apply to either superior oblique palsy or progressive supranuclear palsy unless acute stroke is the presenting concern requiring CT head without contrast or MRI head as initial imaging.